CA2182272C - Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine - Google Patents

Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine Download PDF

Info

Publication number
CA2182272C
CA2182272C CA002182272A CA2182272A CA2182272C CA 2182272 C CA2182272 C CA 2182272C CA 002182272 A CA002182272 A CA 002182272A CA 2182272 A CA2182272 A CA 2182272A CA 2182272 C CA2182272 C CA 2182272C
Authority
CA
Canada
Prior art keywords
protein
papilloma virus
dna
seq
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002182272A
Other languages
English (en)
Other versions
CA2182272A1 (fr
Inventor
Ian Frazer
Jian Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland UQ
CSL Ltd
Original Assignee
University of Queensland UQ
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPM3588A external-priority patent/AUPM358894A0/en
Application filed by University of Queensland UQ, CSL Ltd filed Critical University of Queensland UQ
Publication of CA2182272A1 publication Critical patent/CA2182272A1/fr
Application granted granted Critical
Publication of CA2182272C publication Critical patent/CA2182272C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002182272A 1994-01-31 1995-01-31 Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine Expired - Lifetime CA2182272C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM3588 1994-01-31
AUPM3588A AUPM358894A0 (en) 1994-01-31 1994-01-31 Modified papilloma virus l2 protein and vlps formed therefrom
PCT/AU1995/000043 WO1995020659A1 (fr) 1994-01-31 1995-01-31 Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine

Publications (2)

Publication Number Publication Date
CA2182272A1 CA2182272A1 (fr) 1995-08-03
CA2182272C true CA2182272C (fr) 2006-03-21

Family

ID=36101487

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002182272A Expired - Lifetime CA2182272C (fr) 1994-01-31 1995-01-31 Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine

Country Status (1)

Country Link
CA (1) CA2182272C (fr)

Also Published As

Publication number Publication date
CA2182272A1 (fr) 1995-08-03

Similar Documents

Publication Publication Date Title
Zhou et al. Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence
Hofmann et al. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae
JP4520034B2 (ja) パピローマウイルスカプソメアワクチン製剤及び使用方法
Kirnbauer et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
Müller et al. Chimeric papillomavirus-like particles
Zhang et al. Expression of Human Papillomavirus Type 16 L1 Protein inEscherichia coli: Denaturation, Renaturation, and Self-Assembly of Virus-like Particlesin Vitro
NZ285941A (en) Papillomavirus vaccine and recombinant virus-like particles comprising human papillomavirus protein
Paintsil et al. Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not required for capsid formation
US7279306B2 (en) Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof
RU2161651C2 (ru) Очищенные белки вируса папилломы
FI121507B (fi) Tyyppiä 6A olevaa ihmisen papillomavirusta koodaava DNA
EP0750669B1 (fr) Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine
US6991795B1 (en) Protein delivery system using human papillomavirus virus-like particles
CA2339324C (fr) Systeme de distribution de proteine utilisant des particules humaines de type papillomavirus
CA2182272C (fr) Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine
AU682092C (en) Modified papilloma virus L2 protein and VLPs formed therefrom
AU682092B2 (en) Modified papilloma virus L2 protein and VLPs formed therefrom
ZHOU et al. L2 N-Terminal Sequence
CA2204266C (fr) Proteines purifiees du papillomavirus
AU717932B2 (en) Chimeric papillomavirus-like particles
MXPA00003358A (en) Papilloma virus capsomere vaccine formulations and methods of use

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20150202